Introduction
============

*Pseudomonas aeruginosa* is a versatile Gram-negative bacterium that is an important opportunistic human pathogen. Although this organism does not cause bloodstream infections in patients with chronic respiratory infections despite long-term colonization, it can be invasive in other patients and cause bacteremia associated with high mortality rates, particularly in those with neutropenia. We have reported that most clinical blood isolates cause lethal endogenous bacteremia in leukopenic mice, whereas human respiratory isolates do not cause bacteremia ([@bib1], [@bib2]). We have also reported that clinical blood isolates of *P. aeruginosa* penetrate human intestinal Caco-2 and Madin-Darby canine kidney (MDCK)[\*](#fn1){ref-type="fn"} epithelial cell monolayers to a greater extent than do respiratory isolates ([@bib3], [@bib4]). In the MDCK epithelial cell monolayer system, PAO1 and most blood isolates are invasive but lack *exoU*, which encodes a 70-kD cytotoxic protein ExoU ([@bib5], [@bib6]), and showed high penetration ability without severe epithelial damage. In contrast, PA103 and ∼8% of clinical isolates are cytotoxic, possess *exoU*, and pass through the monolayer after epithelial cell death ([@bib4]).

*P. aeruginosa* is intrinsically resistant to conventional penicillins and cephems due to its low outer membrane (OM) permeability coupled to the production of an inducible chromosomal β-lactamase, which hydrolyzes these β-lactams ([@bib7]) and can become mutationally resistant to even newly-developed antipseudomonal agents ([@bib8]). In addition to the recent emergence of metallo-β-lactamase producing *P. aeruginosa* ([@bib9]), multidrug resistant (MDR) efflux systems are becoming recognized as important antimicrobial resistance mechanisms for this organism. To date, four resistance-nodulation-division (RND) MDR efflux systems have been described in *P. aeruginosa*: MexAB-OprM ([@bib10]--[@bib13]); MexCD-OprJ ([@bib14]); MexEF-OprN ([@bib15]); and MexXY-OprM ([@bib16], [@bib17], for a review, see references [@bib18]--[@bib21]). The genes encoding these systems are arranged as operons, with the first gene encoding a linker protein that is associated with the cytoplasmic membrane (MexA, MexC, MexE, and MexX). The second gene encodes an efflux pump that exports substrates across the inner membrane (MexB, MexD, MexF, and MexY). In three cases, a third gene encodes an OM protein, which facilitates passage of the substrate across the OM (OprM, OprJ, and OprN). OprM is also involved in the MexXY-OprM system ([@bib16], [@bib22]). The three components form a channel that traverses the inner membrane, periplasm, and OM and allows the substrate to be effluxed directly from the cytoplasm or cytoplasmic membrane to the extracellular environment ([@bib18]). Among these four efflux systems, only MexAB-OprM is expressed constitutively in wild-type (WT) *P. aeruginosa*. It was the first *P. aeruginosa* MDR efflux system to be described, and contributes to intrinsic resistance to a number of antimicrobials, such as fluoroquinolones, β-lactams, tetracycline, macrolides, chloramphenicol, novobiocin, trimethoprim, and sulphonamides ([@bib18]). In contrast, other systems have different substrate spectra and are not expressed during normal laboratory growth ([@bib18]). In addition to medically relevant antibiotics, MexAB-OprM also exports a variety of dyes, detergents, inhibitors of fatty acid biosynthesis, and organic solvents ([@bib18]). Hence, this and other RND efflux systems are generally thought to expel harmful substances from bacteria.

Recently, certain studies have suggested a relationship between efflux and virulence in *P. aeruginosa*. For instance, it has been reported that MexAB-OprM exports homoserine lactones which are involved in quorum sensing (cell-to-cell signaling; references [@bib23]--[@bib25]) and consequent regulation of the expression of a variety of virulence determinants. Thus, *nalB* mutants which hyperexpress the MexAB-OprM efflux system produce reduced levels of several extracellular virulence factors ([@bib25]). Other studies have demonstrated that, compared with WT, *nfxC* type mutants, overexpressing the MexEF-OprN efflux system, produce lower levels of pyocyanin, elastase, and rhamnolipids, which are controlled by the *las* and *rhl* quorum-sensing systems ([@bib26], [@bib27]). It has also been suggested that MexAB-OprM contributes to the antibiotic resistance of *P. aeruginosa* biofilms ([@bib28]), while other studies have reported the obverse indicating that the four characterized efflux systems described above did not play a significant role in the resistance of *P. aeruginosa* biofilm to antibiotics ([@bib29]). However, the role of efflux systems in specific clinical pathogenesis of *P. aeruginosa*, including invasiveness, has not been determined.

To gain a better understanding the role of efflux in bacterial pathogenesis, the invasiveness of *P. aeruginosa* PAO1 and its efflux mutants was evaluated using in vitro MDCK epithelial cell monolayer penetration ([@bib4], [@bib30], [@bib31]) and gentamicin survival ([@bib31], [@bib32]) assays, and by electron microscopy. Virulence was also investigated in a murine model of endogenous *P. aeruginosa* bacteremia, closely mimicking the pathophysiology of septicemia in humans ([@bib2], [@bib33], [@bib34]).

Materials and Methods
=====================

Bacterial Strains and Construction of Mutants.
----------------------------------------------

Bacterial strains and plasmids used in this study are summarized in the [Table I](#tbl1){ref-type="table"}. *P. aeruginosa* PAO1 strain K767 ([@bib35]) was used as the WT, which is invasive and penetrates MDCK cell monolayers by 3 h after infection ([@bib4]). Strain K767 lacks *exoU* and did not show any cytotoxicity to MDCK cells within 6 h after infection. To construct *P. aeruginosa* deletion mutants, the deletions were first made in *sacB*-containing vectors and were subsequently introduced into the chromosome of K767 by gene replacement ([@bib36]). The *mexAB-oprM* deletion strain K1119 ([@bib37]) and the *mexCD-oprJ* deletion strain K1521 ([@bib29]) were constructed using the *mexAB-oprM* deletion construct pRSP21 and the *mexCD-oprJ* deletion construct pRSP05, respectively, using the strategy reported previously ([@bib38]). In these instances, however, the selections of transconjugants carrying a copy of pRSP21 or pRSP05 were on Luria-Bertani (LB) agar containing 1.5 mg of kanamycin per ml. The *mexXY* deletion strain K1525 was constructed as described previously ([@bib29]). To construct the *mexB* deletion strain K1523, a 4.6--kb KpnI-HindIII fragment from pRSP19 ([@bib39]), containing *mexA* and part of *mexB*, was first cloned into pEX18Tc to generate pRSP77. Plasmid pRSP77 was digested with BamHI and MluI at two unique sites within *mexB*, 1.8-kb apart, and the 9.1-kb fragment containing the vector was isolated. This fragment was treated with Klenow (New England Biolabs) to facilitate back filling of the 3′ recessed ends and ligated to yield pRSP81. The internal deletion in *mexB* created in this manner was confirmed to be in-frame by sequencing pRSP81 with primer bacmexbf1 (5′-ATG TCG AAG TTT TTC ATT GAT AGG-3′). Plasmid pRSP81 was mobilized into *P. aeruginosa* strain K767 and a chromosomal *mexB* deletion selected using the protocol described previously for the *mexXY* deletion ([@bib29]).

###### 

Bacterial Strains and Plasmids Used in this Study

  Strain or plasmid         Relevant genotype or phenotype                            Source or reference
  ------------------------- --------------------------------------------------------- ---------------------
  *P. aeruginosa* strains                                                             
  K767                      WT PAO1                                                   [@bib35]
  K1119                     K767 Δ*mexAB-oprM*; MexAB-OprM deletion strain            [@bib37]
  K1521                     K767 Δ*mexCD-oprJ*; MexCD-OprJ deletion strain            [@bib29]
  K1523                     K767 Δ*mexB*; MexB deletion strain                        this study
  K1525                     K767 Δ*mexXY*; MexXY deletion strain                      [@bib29]
  OCR1                      K767 *nalB*; MexAB-OprM overproducing strain              [@bib35]
  K1536                     K767 *nfxB*; MexCD-OprJ overproducing strain              this study
  KG4521                    K767 *oprM*:Sm; *oprM* knockout mutant                    this study
  Plasmids                                                                            
  pRK415                    Broad-host-range cloning vector, tetracycline-resistant   [@bib40]
  pRSP17                    pRK415:*mexAB-oprM*; *mexAB-oprM* expression plasmid      [@bib39]
  pKMM128                   *oprM* expression plasmid, carbenicillin-resistant        [@bib45]

The chromosomal deletion of *mexB* was confirmed by PCR using primers rspoligo3 (5′-CAG CAG CTC TAC CAG ATC GAC-3′) and rspoligo4 (5′-GTG TCC TTG GTC AGC TGC AAC-3′). The *nfxB* strain K1536 was obtained after plating strain K767 on LB plates containing 0.4 μg ciprofloxacin (Sigma-Aldrich) per ml. Those overexpressing MexCD-OprJ were confirmed by immunoblotting of cell envelopes with antibodies specific to OprJ as described previously ([@bib38]). The *nalB* strain OCR1 has been described previously ([@bib35]). Plasmids pRK415 ([@bib40]) and its derivative pRSP17 ([@bib39]), which carries *mexAB-oprM* were maintained in strain K1119 (Δ*mexAB-oprM*) by inclusion of tetracycline (10 μg/ml) in the growth media. To constructe a *oprM* knockout mutant derived from K767 (WT), PCR primers for amplification of the 1.5-kb fragment were synthesized based on nucleotide sequences of the *Pseudomonas* genome sequencing project database. After amplifying a 1.5-kb region including *oprM* gene ([@bib11]) on strain K767 (WT) genomic DNA as a template using \#oprM4 (5′-TCAT[AAGCTT]{.ul}ATGAAAACGGTCCTTCCTTTCC-3′) and \#oprM3 (5′-TTGA[GAATTC]{.ul}TCAAGCCTGGGGATCTTCCTT-3′), a primer pair containing a newly added cutting site (underlined) for restriction nucleases, the region was ligated into the HindIII-EcoRI site in a multicloning site of pMT5059 ([@bib41]) to yield pMT5059M. The SalI fragment encompassing ΩSm gene from pS1918 ([@bib42]) was ligated into the SalI site in the *oprM* gene on pMT5059M to yield pMT5059MSM. Then, the Mob cassette from pMT5071 ([@bib43]) was cloned into the NotI site, on pMT5059 ([@bib41]) to yield pMK1. The resulting plasmid was mobilized from the *E. coli* strain S17--1 to K767 (WT) to introduce the streptomycin-resistant determinant into the *oprM* gene on the recipient chromosomes to yield KG4521. Disruption of the *oprM* gene of KG4521 was confirmed by PCR and Western immunoblot analysis using the anti-OprM antibody ([@bib44]) (unpublished data). Plasmid pKMM128 ([@bib45]) carrying *oprM* was maintained in KG4521 (Δ*oprM*) in the presence of 10 μg/ml of carbenicillin. All mutants derived from K767 were motile, resistant to 10% pooled fresh normal human serum, noncytotoxic, and grew in LB broth and MEM as well as their parent strain K767.

MDCK Cell Monolayer Penetration Assay.
--------------------------------------

The assay was performed as reported previously ([@bib4], [@bib30], [@bib31]). In brief, strain 1 MDCK cells in MEM with 10% FBS were seeded at 1.5 × 10^5^ cells per well in Transwell filter units (Costar) containing 0.33-cm^2^ porous filter membranes (3.0-μm pores). Monolayers were incubated at 37°C in 5% CO~2~ for 4 d until the transmonolayer electrical resistance (TER) reached the proper range (900--1,200 Ωcm^2^), as measured with a Millicell-ESR apparatus (Millipore). Monolayers were infected with bacteria by adding 5 μl (3.5 × 10^6^ CFU) freshly grown bacteria cultured in LB broth overnight at 37°C with shaking at 150 rpm. In some experiments, TER was monitored at several time intervals after infection to assess damage to monolayers. The assay was performed in triplicate, and results are expressed as an average ± SD. Each assay was repeated at least three times to confirm the reproducibility.

Bacterial Association and Invasion Assay.
-----------------------------------------

Gentamicin survival assays were performed to quantify the bacteria which invaded MDCK cells ([@bib31], [@bib32]). After a 3-h infection, monolayers were washed six times with PBS and then incubated a further 2 h in fresh medium containing 200 μg/ml of gentamicin to kill extracellular bacteria only. Monolayers were washed three times with PBS and then lysed with a 1% Triton X-100 (Sigma-Aldrich) for 15 min. Appropriate dilutions were spread onto agar plates, incubated at 37°C overnight, and CFUs counted to quantify bacteria surviving intracellularly. Associated bacteria (including both adherent and invading bacteria) were measured by the addition of a 1% Triton X-100 to the monolayers 3 h after infection followed by six washes without gentamicin treatment. As a control, filter units with medium only and without MDCK cells were inoculated with bacteria to determine baseline adherence to plastic. The baseline values were subtracted from those obtained by incubation with epithelial cells as described above.

Electron Microscopy.
--------------------

For transmission electron microscopy (TEM), monolayers infected with bacteria were washed seven times with PBS at 37°C and fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate containing 2 mM CaCl~2~ (cacodylate buffer) for 60 min. After washing with cacodylate buffer, samples were postfixed in cold 1% OsO~4~ in the same buffer for 30 min, and then stained with cold 2% uranyl acetate for 30 min. Samples were dehydrated in a series of ethanol and embedded in EPON 812 resin, and were sectioned and stained with uranyl acetate and lead citrate before examination in a JEOL JEM-1210 transmission electron microscope. For scanning electron microscopy (SEM), the monolayers were fixed as described above, dehydrated in a critical point apparatus, and were examined with a JEOL JSM-35C/LaB~6~ III--A scanning electron microscope, after a gold sputter coating.

Evaluation of Virulence of the Efflux Mutants in a Murine Model of Endogenous Bacteremia.
-----------------------------------------------------------------------------------------

The animal studies were approved by the Animal Care and Use Committee of Nagasaki University, and were conducted in accordance to the Guidelines for Animal Experimentation, Nagasaki University. Specific-pathogen-free male BALB/c mice (Japan S.L.C. Co., Ltd.) weighing 20--24 g were used in these experiments. Fecal specimens were cultured before the study to ensure the absence of *P. aeruginosa*. Endogenous bacteremia was induced as described previously ([@bib2], [@bib33], [@bib34]). In brief, a suspension of 10^7^ CFU/ml *P. aeruginosa* in sterile 0.45% saline was given in the drinking water between days 1 and 4. The normal intestinal flora of the mice was disturbed by administration of sodium ampicillin (Meiji Seika Kaisha, Ltd.) by daily intraperitoneal injection during the same period, to assist in the colonization by *P. aeruginosa*. Mice were then given 200 mg/kg cyclophosphamide (Shionogi & Co.) by intraperitoneal injection on days 5, 7, and 9. These doses of cyclophosphamide induce leukopenia (\<1,000/mm^3^) in mice from days 8 to 14 without lethality in the absence of oral bacterial inoculation ([@bib33], [@bib34]).

Effect of Monolayer Supernates on Penetration of P. aeruginosa Strains.
-----------------------------------------------------------------------

The supernates of monolayers infected with strains K767 (WT) or K1119 (*ΔmexAB-oprM*) were collected 3 h or overnight after infection of MDCK cells, and diluted appropriately. The medium of the MDCK cell monolayers on day 4 was replaced with these supernates and strains K767 or K1119 were added 1 h later as described above. As controls, the supernates from MDCK cell-free MEM or LB broth inoculated with the strains were also tested.

Statistics.
-----------

Analysis of variance (ANOVA) was used for the comparisons among three or more groups. Student\'s *t* test was used to compare means between the two groups. Chi-square test was used to compare survival rates. A level of 5% was accepted as statistically significant.

Results
=======

Penetration of Strain K767 (WT) and Its Efflux Mutants through MDCK Cell Monolayers.
------------------------------------------------------------------------------------

Both the parent WT strain K767 and strain K1521 (Δ*mexCD-oprJ*) penetrated MDCK monolayers by 3 h, whereas K1119 (Δ*mexAB-oprM*) was not detected in the basolateral medium until 6 h after infection ([Fig. 1](#fig1){ref-type="fig"} A). At all time points, the penetration of both K767 (WT) and K1521 (Δ*mexCD-oprJ*) was significantly greater than that for K1119 (Δ*mexAB-oprM*) (*P* \< 0.0006, ANOVA). Compared with the WT, relative capacities of the mutants to penetrate monolayers at 3 and 6 h after infection are summarized in [Fig. 1](#fig1){ref-type="fig"} B. Strains K1523 (Δ*mexB*) and K1525 (Δ*mexXY*) were also compromised for invasion, but to lesser extents than the mutant with total deletion of *mexAB-oprM* (K1119). The invasive capacities of strains OCR1 (*nalB*) and K1536 (*nfxB*), hyperexpressing efflux systems, were also intermediate between strains K767 (WT) and K1119 (Δ*mexAB-oprM*).

###### 

Penetration of *P. aeruginosa* strain K767 (WT) and its efflux mutants. Bacteria were inoculated at 3.5 × 10^6^ CFU per well to the apical surfaces of MDCK cell monolayers. (A) The assay was performed in triplicate, and results are expressed as mean ± SD. (B) The values are expressed as percentages of values obtained with strain K767 at 3 and 6 h.
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[Fig. 2](#fig2){ref-type="fig"} shows the time course of changes in TER of the MDCK cell monolayers infected with strain K767 (WT) and its efflux mutants. TER of monolayers infected with strains K767 (WT) or K1521 (Δ*mexCD-oprJ*) decreased in a time-dependent manner. The drops in TER for these strains were slower than that for cytotoxic strains, which induced a steep drop ([@bib4]). When monolayers were infected with strain K1119 (Δ*mexAB-oprM*), TER decreased more slowly over time than for strains K767 (WT) and K1521 (Δ*mexCD-oprJ*). The values of TER for strains K1523 (Δ*mexB*) and K1525 (Δ*mexXY*) were always intermediate between those of strains K767 (WT) and K1119 (Δ*mexAB-oprM*).

![Changes of TER after infection with *P. aeruginosa* strain K767 (WT of PAO1) and its efflux mutants. TER was measured in triplicate, and results are expressed as an average ± SD of area multiplied by resistance.](20020005f2){#fig2}

Association and Invasion of Strains K767 (WT) and K1119 (ΔmexAB-oprM).
----------------------------------------------------------------------

Strain K1119 (Δ*mexAB-oprM*) adhered to MDCK cells, as well as K767 (WT) (5.25 ± 1.79 × 10^5^ vs. 4.78 ± 1.21 × 10^5^ CFU, not significant, [Fig. 3](#fig3){ref-type="fig"} A). However, the gentamicin survival assay revealed that the efflux mutant K1119 (Δ*mexAB-oprM*) showed a significantly decreased level of invasion (86.7 ± 9.6 vs. 1.18 ± 0.15 × 10^4^ CFU, *P* = 0.0002, [Fig. 3](#fig3){ref-type="fig"} B). [Fig. 3](#fig3){ref-type="fig"} C shows the time courses of invasion for the strains K767 (WT) and K1119 (Δ*mexAB-oprM*) by the gentamicin survival assay. Significantly greater numbers of K767 (WT) than K1119 (Δ*mexAB-oprM*) invaded the epithelial cells (*P* \< 0.0065, at each time point). Strain K767 (WT), which penetrated monolayers by 3 h ([Fig. 1](#fig1){ref-type="fig"} A), entered the cells within 30 min, and the number of intracellular bacteria per monolayer increased in a time-dependent manner. The small number of K1119 (Δ*mexAB-oprM*) which had transversed the monolayers by 6 h ([Fig. 1](#fig1){ref-type="fig"} A), was reflected in by the low level of invasion by 60 min. The number of intracellular K1119 (Δ*mexAB-oprM*) bacteria also increased in a time-dependent manner, but the value at 360 min was comparable to K767 (WT) only 60 min after infection (200 ± 45 vs. 130 ± 17 CFU, *P* = 0.0653).

![Bacterial association with (A) and invasion into (B and C) MDCK epithelial cells of *P. aeruginosa* strain K767 (WT of PAO1) and its efflux mutant K1119 (Δ*mexAB-oprM*). Bacterial association was evaluated by lysis of the epithelial cells with Triton X-100, 3 h after infection. Bacterial invasion was assessed at indicated times similarly but after the treatment with 200 μg/ml of gentamicin for 2 h to kill extracellular bacteria. The assay was performed in triplicate, and results are expressed as mean ± SD.](20020005f3){#fig3}

Electron Microscopy.
--------------------

When observed by scanning electron microscopy, most of the bacteria, including strain K767 (WT) and its efflux mutants, adhered near the edge (cell-to-cell junctions) of MDCK cells ([Fig. 4](#fig4){ref-type="fig"} A), whereas K767 (WT) showed an additional adherence pattern, adherence around the center of the epithelial cells and seemed to be in the process of invading ([Fig. 4](#fig4){ref-type="fig"} B). The microvilli of MDCK cells, to which *P. aeruginosa* isolates adhered, were grossly unaltered. Transmission electron microscopy showed that K767 (WT) contacted with the epithelial cell surface ([Fig. 4](#fig4){ref-type="fig"} C) and a bacterium was internalized ([Fig. 4](#fig4){ref-type="fig"} D) 15 min after infection. At later time points bacteria invaded into the cells and reached the layer of the polycarbonate filter within 3 h after infection, as reported elsewhere ([@bib46], [@bib47]) but without appearance of cell injury. In contrast, K1119 (Δ*mexAB-oprM*) did not penetrate at all by 30 min, and only a small number of bacteria invaded cells by 3 h after infection (data not shown).

![Scanning (A and B) and transmission (C and D) electron micrographs of MDCK epithelial cell monolayers infected with *P. aeruginosa* strain K767 (WT of PAO1) and its efflux mutants K1119 (Δ*mexAB-oprM*). Bacteria adhere near the edge of the epithelial cells without loss of microvilli (A; K1119, 3 h after infection). Bacteria adhere around the center of the epithelial cells and some bacteria appear to be invading into the MDCK cells, without loss of microvilli (B; K767, 1 h after infection). Bacteria are contacting the epithelial cell surface (C; K767) and a bacterium is internalized into a MDCK cell (D; K767) 15 min after infection. Original magnifications, 4,800× (A and B) and 10,000× (C and D). Bar, 1 μm.](20020005f4){#fig4}

Evaluation of the Virulence of the Efflux Mutants in a Murine Model.
--------------------------------------------------------------------

The animal model used in this study reflects the differences in the important pathophysiological steps in authentic human infections, including bacterial colonization and invasion. All strains of *P. aeruginosa* tested survived equally well in the drinking water; all were recovered at equal titer at the end of the oral bacterial challenge. Furthermore, on day 8, equivalent numbers of *P. aeruginosa* were recovered from the stools of animals challenged with each different bacterial strain. Strains K767 (WT) and K1521 (Δ*mexCD-oprJ*) induced lethal endogenous septicemia in mice, whereas strain K1119 (Δ*mexAB-oprM*) failed to kill any mice (*P* \< 0.0001, [Fig. 5](#fig5){ref-type="fig"} A). The mortality rates of mice given K1523 (Δ*mexB*, 20% mortality rate, *P* \< 0.0001 compared with K767), K1525 (Δ*mexXY*, 55%, *P* = 0.00066), OCR1 (*nalB*, 80%, *P* = 0.035), and K1536 (*nfxB*, 70%, *P* = 0.0079) were intermediate between those for strains K767 (100%) and K1119 (0%) ([Fig. 5](#fig5){ref-type="fig"} B).

###### 

Survival kinetics of leukopenic mice given *P. aeruginosa* strain K767 (WT) and its efflux mutants K1119 (Δ*mexAB-oprM*) and K1521 (Δ*mexCD-oprJ*) (A) and mortality rates of mice given *P. aeruginosa* WT and its efflux mutants (B). Mice were given 200 mg of ampicillin (A) and 200 mg of cyclophosphamide (CY) per kg on the indicated days. Bacteria were given orally in drinking water in sterile 0.45% saline at the concentration of 10^7^ CFU/ml between days 1 and 4. The numbers of mice per group are indicated in the figure. (B) Data are expressed as the mortality rate for each group given a different *P. aeruginosa* strain.
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Influence of Complementation of K1119 (ΔmexAB-oprM) with mexAB-oprM on Its Invasiveness.
----------------------------------------------------------------------------------------

To confirm the role of *mexAB-oprM* in the expression of invasiveness, the Δ*mexAB-oprM* deletion strain K1119 was complemented with *mexAB-oprM* by introducing plasmid pRSP17 carrying the genes and examined with strains K767 (WT), K1119 (Δ*mexAB-oprM*), and K1119/pRK415 (plasmid control). K1119/pRSP17 (*mexAB-oprM* complemented strain) showed the invasiveness equivalent to WT in both in vitro ([Fig. 6](#fig6){ref-type="fig"} A) and the animal model ([Fig. 6](#fig6){ref-type="fig"} B), while plasmid control strain K1119/pRK415 had the same phenotype, which was compromised in its capacity to penetrate MDCK monolayer ([Fig. 6](#fig6){ref-type="fig"} A, *P* \< 0.0001) and to kill leukopenic mice ([Fig. 6](#fig6){ref-type="fig"} B, *P* \< 0.0001) as K1119 (Δ*mexAB-oprM*).

###### 

Penetration of *P. aeruginosa* strain K767 (WT), K1119 (Δ*mexAB-oprM*), *mexAB-oprM* complemented strain, and *oprM* knockout mutant (A) and mortality rates of leukemic mice given the *P. aeruginosa* strains (B). Strains K1119/pRSP17 and K1119/pRK415 are K1119 (Δ*mexAB-oprM*), complemented with *mexAB-oprM* and its plasmid control, respectively. KG4521 and KG4521/pKMM128 are *oprM* knockout mutant from K767 and *oprM* complemented mutant of KG4521, respectively. The assay was performed in triplicate, and results are expressed as mean ± SD (A). Data are expressed as the mortality rate for each group (at least 10 mice per group) given a different *P. aeruginosa* strain (B).
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Influence of a Single Mutation in oprM on the Invasiveness of P. aeruginosa.
----------------------------------------------------------------------------

A *oprM* knockout mutant KG4521 was examined with K767 (WT) and KG4521/pKMM128 (*oprM* complemented strain) to clarify the role of OprM in the loss of virulence in *P. aeruginosa*. Strain KG4521 (*oprM* knockout) was significantly less virulent in the MDCK epithelial monolayer system ([Fig. 6](#fig6){ref-type="fig"} A, *P =* 0.0466) and in the animal model ([Fig. 6](#fig6){ref-type="fig"} B, *P =* 0.02703). However, the loss of virulence was modest compared with the complete *mexAB-oprM* deletion mutant K1119. Complementation of KG4521 with *oprM* restored the virulence entirely ([Fig. 6](#fig6){ref-type="fig"}).

Effect of Monolayer Supernates on Penetration of P. aeruginosa Strains.
-----------------------------------------------------------------------

Experiments were performed to determine if soluble factors enhanced the penetration of *P. aeruginosa* across MDCK cells. Neither supernates of K767 (WT) or K1119 (Δ*mexAB-oprM*) cultured overnight in cell-free LB broth, nor K1119 (Δ*mexAB-oprM*) cultured overnight in MEM in the presence of MDCK cells, when readded to MDCK cells, influenced the penetration of K767 (WT). On the other hand, the supernate from MDCK cells incubated overnight together with K767 (WT), caused a slight but significant enhancement of the penetration of strain K767 (WT) itself into MDCK monolayers (*P* = 0.0475, ANOVA). Supernates from MDCK cell monolayers infected overnight with K767 (WT) dramatically and significantly enhanced the penetration of K1119 (Δ*mexAB-oprM*) into MDCK cells (*P* \< 0.0001, ANOVA). The K1119 (Δ*mexAB-oprM*) supernate also significantly enhanced the penetration of K1119 (Δ*mexAB-oprM*) (*P* \< 0.05), but the effect was nearly 10-fold less than that observed with the K767 (WT) supernate (245 ± 128 vs. 2320 ± 385, *P* = 0.0081) ([Fig. 7](#fig7){ref-type="fig"} A). The supernates of K767 (WT) incubated in MEM in the absence of MDCK cells showed a very low level of enhancement of invasion of the K1119 (Δ*mexAB-oprM*) cells (unpublished data). The supernates of strain K767 (WT) incubated with MDCK cells overnight, enhanced the penetration of strain K1119 (Δ*mexAB-oprM*) through monolayers in a concentration-dependent manner ([Fig. 7](#fig7){ref-type="fig"} B). In contrast, the supernates obtained 3 h after infection demonstrated a relatively weak enhancement effect compared with those from overnight cultures.

###### 

Influence of bacterial culture supernates on penetration of *P. aeruginosa* strain K767 (WT of PAO1) and its efflux mutant K1119 (Δ*mexAB-oprM*) (A) and the effect of concentration of supernates (B). MDCK cell monolayers were infected with K767 or K1119 overnight and the supernates were collected. Medium of MDCK cell monolayers were replaced 1 h before infection with the supernates obtained in the different condition as described. Fresh MEM was used as a control. The assay was performed in triplicate, and results are expressed as mean ± SD. Legend: sup in LB, bacterial culture supernate from LB broth; sup in MEM/MDCK, bacterial culture supernate from MDCK cell monolayer infected with bacteria;. sup 3 h, bacterial culture supernate from MDCK cell monolayer infected for 3 h; sup O/N, bacterial culture supernate from MDCK cell monolayer infected overnight.
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Discussion
==========

This study using MDCK epithelial cell monolayer system demonstrates an association between bacterial efflux mechanisms and invasion of eukaryotic cells. The Δ*mexAB-oprM* deletion strain K1119 was the least invasive among the efflux mutants tested, while K1521, the *mexCD-oprJ* deletion strain, was as invasive as WT. The loss of only *mexB* (K1523) or *mexXY* (K1525) decreased invasion but in a less dramatic fashion than for the deletion of the entire *mexAB-oprM* operon (K1119). Data from gentamicin survival assays, electron microscopy studies, and the animal studies supported these findings. The current in vitro and in vivo animal models represent intestinal epithelium and gut-derived endogenous bacteremia, respectively, but not respiratory epithelium nor pneumonia models. Mex and OM proteins may influence the bacterial susceptibility to antibody independent complement killing or opsonic killing by neutrophils; however, all mutants in this study were serum-resistant as the WT, suggesting that the mutations did not affect their susceptibility to antibody-independent complement killing. This study did not include phagocytes in the in vitro system and our animal model was leukopenic. Therefore, we do not believe that the changes we observed in the mutants influenced their interactions with phagocytic cells.

Our data suggest that deletion of all three genes in the MexAB-OprM efflux system is necessary to yield the maximum loss of invasiveness. The complementation of Δ*mexAB-oprM* deletion strain K1119 with *mexAB-oprM* restored the invasiveness to the level of WT, and consequently confirmed that the genes, *mexAB-oprM*, actually played an important role in the loss of invasiveness. The MexXY-OprM and MexAB-OprM systems share OprM as a channel-tunnel ([@bib16], [@bib17]), and only the deletion of genes in these two efflux systems decreased the level of invasiveness modestly. However, the *mexB* deletion strain K1523 displayed a more similar phenotype to the complete *mexAB-oprM* mutant K1119 than the *mexXY* mutant K1525. The difference in virulence between the Δ*mexB* mutant and the Δ*mexXY* mutant may depend on the expression of each efflux system; MexAB-OprM is expressed constitutively. We expected that OprM is a critical determinant of invasiveness in *P. aeruginosa* and that the invasive determinant(s) are exported through OprM only; however, the loss of invasiveness in the *oprM* knockout mutant, KG4521 was modest, suggesting the possibility that OM proteins other than OprM also could work with MexAB.

The efflux system-overproducing strains such as *nalB* and *nfxB*, also demonstrated somewhat reduced invasiveness, akin to the efflux deletion strains ([Fig. 1](#fig1){ref-type="fig"} B). These paradoxical findings may be explained by recent reports, which showed that *nalB* type mutants, hyperexpressing the MexAB-OprM ([@bib23]--[@bib25]) and *nfxC* type mutants, overexpressing the MexEF-OprN ([@bib26], [@bib27]), produce lower level of virulence factors because of their influence on cell-to-cell signaling regulated by quorum-sensing systems. Therefore, it appears that normal efflux levels are necessary for *P. aeruginosa* to express maximal invasiveness.

Data from gentamicin survival assays ([Fig. 3](#fig3){ref-type="fig"} A) and electron microscopy studies ([Fig. 4](#fig4){ref-type="fig"} A) also confirmed that the differences between WT and the Δ*mexAB-oprM* mutant in bacterial penetration through MDCK epithelial cell monolayers, were correlated with differences in their invasiveness; the strains adhered to the epithelial cells equally well. Electron microscopy studies showed a very similar invasion pattern to that reported in the study using tracheal epithelial cells ([@bib48]). Interestingly, in contrast to the observation of microvilli loss when MDCK cells are infected with *Salmonella* isolates for at least 2 h ([@bib31]), microvilli appeared to remain intact when such cells were infected with *P. aeruginosa* strains for at least 3 h. The difference between the two bacterial species is consistent with the observation that *P. aeruginosa* frequently colonizes the intestine of normal human subjects ([@bib49]) without producing any symptoms, and shares characteristics with normal enteric microbial flora. Conversely, *Salmonella* species are not part of the normal flora and have the capacity to cause invasive disease in normal hosts. The molecular mechanisms accounting for differences in the pathology of disease in the gastrointestinal tract remains unexplained in spite of the reported use of the cystic fibrosis transmembrane conductance regulator by both *Salmonella typhi* and *P. aeruginosa* to enter epithelial cells ([@bib50]--[@bib52]). Recently, it has been reported that *S. typhi* LPS is altered by contact with epithelial cells, exposing the bacterial ligand for cystic fibrosis transmembrane conductance regulator on the LPS ([@bib53]). Similar findings in *P. aeruginosa*--epithelial cell interaction could further clarify the molecular mechanisms of invasion for this bacterial species.

Our previous study demonstrated that noncytotoxic isolates of *P. aeruginosa*, including PAO1, expressed minimal epithelial cell damage; PAO1 did not induce LDH release from MDCK cells or the formation of plaques as detected by staining with trypan blue at 6 h after infection; cytotoxic isolates showed clear evidence of cell damage within 3 h ([@bib4]). In this study, changes in TER of monolayers infected with the efflux mutants, in particular the *mexAB-oprM* deletion strain, were substantially less than for the WT ([Fig. 2](#fig2){ref-type="fig"}). These findings may mean that bacterial invasion may disrupt the tight junctions between epithelial cells even though they do not induce demonstrable cytotoxicity.

The supernates from MDCK cells infected overnight with WT restored the capacity of the Δ*mexAB-oprM* strain K1119 to penetrate monolayers in a concentration-dependent manner ([Fig. 7](#fig7){ref-type="fig"}). When the WT strain was added from the basolateral side, neither the basolateral nor apical supernates showed any enhancing effect (data not shown). The enhancement of invasion by the K1119 (Δ*mexAB-oprM*) supernate was modest, and much less than by the WT supernate, suggesting that other efflux systems may export virulence determinants, albeit to a lesser degree than for MexAB-OprM. These findings strongly indicate that WT exports invasion determinant(s) into the extracellular environment, using predominantly MexAB-OprM (with lesser contributions by MexXY-OprM or other undetermined systems). It remains to be determined if the putative determinant(s) of invasiveness act directly as invasive factor(s) or as regulatory factor(s). Although it is still possible that mammalian products could be involved in the findings, studies are currently underway to purify and determine the molecular nature of the determinant(s) in the bacterial supernate which confer invasiveness.

The recovery of invasiveness of the *mexAB-oprM* deletion strain, mediated by the supernate of WT, required cell-to-cell contact between the bacterium and MDCK cells ([Fig. 7](#fig7){ref-type="fig"}). These data suggest that the type III protein secretion system (for a review, see reference [@bib54]) may be involved in the expression of invasiveness in *P. aeruginosa*. Type III secretion systems require close contact between bacterium and eukaryotic cell in order to deliver virulent bacterial proteins directly into the cytoplasm of the cell. ExoU and some other exoenzymes are recognized type III effectors in *P. aeruginosa* ([@bib55]). In other bacterial species such as *Salmonella*, the bacteria modulate actin organization to induce their own uptake by nonphagocytic cells ([@bib56], [@bib57]). Efflux protein homologues can secrete proteins since type I secretion systems are RND homologues ([@bib58]). However, the relation of efflux systems to the type III protein secretion system has not been demonstrated to date, and proteins secreted by the type III systems are likely too large for export via MDR efflux systems. Therefore, it is possible that contact of bacteria with the epithelial cells may be a trigger to stimulate the efflux of invasiveness determinant(s).

Our findings in this study strongly suggest that invasion determinant(s) are predominantly exported by *P. aeruginosa* via MexAB-OprM. Hence, MDR efflux systems in *P. aeruginosa* might be critical for the efflux of virulence factors, in addition to their established role of exporting harmful substances such as antibiotics or detergents. It seems practical for bacteria to utilize efflux systems to export virulence determinants and physiological products, as a physiological process. In fact, recent reports suggest that *E. coli* expels bacterial cellular metabolites such as indole and bile acids using the efflux systems AcrEF ([@bib59]) and AcrAB ([@bib60]), respectively. Our findings are consistent with a novel physiological role for such "multidrug" efflux systems, namely in enhancing bacterial invasiveness in *P. aeruginosa* infections. Furthermore, efflux inhibitors, which are under development to depress MDR by efflux systems ([@bib61]), may also serve to reduce bacterial invasiveness in *P. aeruginosa* infections.

We are grateful to B. Brett Finlay for helpful suggestions. We thank Shadi Neshat and Takeshi Murata for the construction of mutants; Kelly MacDonald for serum sensitivity testing; Manjeet Bains for technical expertise and discussions; and Elaine Humphrey and Ashka Patel for helping in the sample preparation for electron microscopy.

Y. Hirakata was supported by Uehara Memorial Foundation, Canadian Cystic Fibrosis Foundation (CCFF), and British Columbia Lung Association, and by a Grant-in-Aid for Scientific Research in 2001 (13877042) from Japan Society for the Promotion of Science. R. Srikumar was a recipient of a Postdoctoral Fellowship from the CCFF. K. Poole and D.P. Speert were supported by grants from the CCFF. K. Poole is a CCFF scholar. R.E.W. Hancock is a Canada Research Chair in Microbiology and his research was supported by the Canadian Institutes of Health Research.

*Abbreviations used in this paper:* ANOVA, analysis of variance; LB, Luria-Bertani; MDCK, Madin-Darby canine kidney; MDR, multidrug resistant; OM, outer membrane; RND, resistance-nodulation-division; TER, transmonolayer electrical resistance; WT, wild-type.

[^1]: Address correspondence to Yoichi Hirakata, Dept. of Laboratory Medicine, Nagasaki University School of Medicine, Nagasaki 852-8501, Japan. Phone: 81-95-849-7418; Fax: 81-95-849-7257; E-mail: <hirakata@net.nagasaki-u.ac.jp>
